Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
about
Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic StrokeMatrix metalloproteinases in kidney homeostasis and diseasesMatrix metalloproteinase 10 gene polymorphism and atherothrombotic cerebral infarction risk in a Han Chinese populationGenetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms.Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patientsIncreased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion.Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.Inflammation in atherosclerosis: a cause or a result of vascular disorders?A pharmacogenomic profile of human neural progenitors undergoing differentiation in the presence of the traditional Chinese medicine NeuroAiD.Temporal analysis of blood-brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke.Association of matrix metalloproteinase-10 polymorphisms with susceptibility to pelvic organ prolapse.proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke.Aldose reductase inhibitor counteracts the enhanced expression of matrix metalloproteinase-10 and improves corneal wound healing in galactose-fed ratsMatrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair.Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients.CM352 Reduces Brain Damage and Improves Functional Recovery in a Rat Model of Intracerebral Hemorrhage.New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.Cystamine improves functional recovery via axon remodeling and neuroprotection after stroke in mice.MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy.Induction of oxidative stress by oxidized LDL via meprinα-activated epidermal growth factor receptor in macrophages.The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.Post-stroke mRNA expression profile of MMPs: effect of genetic deletion of MMP-12
P2860
Q26766038-053AA83B-B978-4766-AAEB-72566087988BQ27004621-4E30AC86-1254-40CC-B5A4-AE0A0A13E795Q28689904-71649906-808B-4FD6-9A1E-1FEB70650653Q33572001-C6F41480-AD04-465A-8415-A642483772F2Q35161646-C629293A-CF52-4A1D-86B4-05090CD711DAQ35595010-4D2992C0-4D33-4FA6-82D5-F521E76F06A1Q35610722-AE4C0DEB-183B-45D7-9320-1FE9368988C5Q36736442-E1D87E7E-FA7E-4AEE-A229-693387A55DD9Q37986175-30A3E2A1-C7A3-40EC-9DB6-4797FC59BC22Q38780762-617704AF-DBC6-4B31-8409-2FB98DDA3E21Q39155405-2E66AB6A-5333-490B-A5EA-A17498827E8BQ40485607-0938E778-9660-44B2-8AE9-81779ED56A14Q42710833-96322A93-8408-46F9-9D25-128358AAE3D6Q42830242-25419048-2387-4EAC-8896-02C519A3BAC0Q45857193-2F2CCC18-550F-49E8-BC6D-B7FA8BD9F8C7Q46068772-232B18ED-CB42-4700-A1B3-E313C9699CA7Q47165301-1D019848-905A-475E-BAF6-E53E02320DB7Q48229194-4C6C0A48-51EC-46C2-8738-1EF914E39CF7Q48445336-05FCFBD1-8579-4245-A827-DE87F2AB3DC0Q53086675-AC191A54-1EBC-4B89-BDE7-2BDD24CE88C8Q54464757-8F03151E-63BE-4D08-9C8E-9613665EDE73Q55021545-5FF3B959-0F3C-4987-BB2B-155FED23789FQ57193130-18CEF68E-2AD3-4777-90F3-F5567C549EEA
P2860
Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Matrix metalloproteinase-10 ef ...... inhibitor-mediated mechanism.
@ast
Matrix metalloproteinase-10 ef ...... inhibitor-mediated mechanism.
@en
Matrix metalloproteinase-10 ef ...... inhibitor-mediated mechanism.
@nl
type
label
Matrix metalloproteinase-10 ef ...... inhibitor-mediated mechanism.
@ast
Matrix metalloproteinase-10 ef ...... inhibitor-mediated mechanism.
@en
Matrix metalloproteinase-10 ef ...... inhibitor-mediated mechanism.
@nl
prefLabel
Matrix metalloproteinase-10 ef ...... inhibitor-mediated mechanism.
@ast
Matrix metalloproteinase-10 ef ...... inhibitor-mediated mechanism.
@en
Matrix metalloproteinase-10 ef ...... inhibitor-mediated mechanism.
@nl
P2093
P50
P1433
P1476
Matrix metalloproteinase-10 ef ...... s inhibitor-mediated mechanism
@en
P2093
J Barrenetxe
S Martinez de Lizarrondo
T P Birkland
P304
P356
10.1161/CIRCULATIONAHA.111.047100
P407
P577
2011-11-21T00:00:00Z